Related references
Note: Only part of the references are listed.Reassessing the clinical spectrum associated with hereditary leiomyomatosis and renal cell carcinoma syndrome in French FH mutation carriers
M. Muller et al.
CLINICAL GENETICS (2017)
Fumarate Hydratase-deficient Renal Cell Carcinoma Is Strongly Correlated With Fumarate Hydratase Mutation and Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome
Kiril Trpkov et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2016)
Tubulocystic Carcinoma of the Kidney With Poorly Differentiated Foci A Frequent Morphologic Pattern of Fumarate Hydratase-deficient Renal Cell Carcinoma
Steven C. Smith et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2016)
Immunohistochemistry for 2-Succinocysteine (2SC) and Fumarate Hydratase (FH) in Cutaneous Leiomyomas May Aid in Identification of Patients With HLRCC (Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome)
Benjamin Buelow et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2016)
The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours
Holger Moch et al.
EUROPEAN UROLOGY (2016)
Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition
Marco Sciacovelli et al.
NATURE (2016)
Morphology and Immunohistochemistry for 2SC and FH Aid in Detection of Fumarate Hydratase Gene Aberrations in Uterine Leiomyomas From Young Patients
Nancy M. Joseph et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2015)
Hereditary Leiomyomatosis and Reenal Cell Carcinoma Syndrome-associated Renal Cancer Recognition of the Syndrome by Pathologic Features and the Utility of Detecting Aberrant Succination by Immunohistochemistry
Ying-Bei Chen et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2014)
Hereditary leiomyomatosis and renal cell cancer (HLRCC): renal cancer risk, surveillance and treatment
Fred H. Menko et al.
FAMILIAL CANCER (2014)
Fumarate hydratase immunohistochemical staining may help to identify patients with multiple cutaneous and uterine leiomyomatosis (MCUL) and hereditary leiomyomatosis and renal cell cancer (HLRCC) syndrome
M. Llamas-Velasco et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2014)
The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia
John R. Srigley et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2013)
Succination of proteins in diabetes
Norma Frizzell et al.
FREE RADICAL RESEARCH (2011)
Novel FH mutations in families with hereditary leiomyomatosis and renal cell cancer (HLRCC) and patients with isolated type 2 papillary renal cell carcinoma
Betty Gardie et al.
JOURNAL OF MEDICAL GENETICS (2011)
Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status
Chiara Bardella et al.
JOURNAL OF PATHOLOGY (2011)
The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome
Maria J. Merino et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2007)
Hereditary leiomyomatosis and renal cell cancer: A syndrome associated with an aggressive form of inherited renal cancer
Robert L. Grubb et al.
JOURNAL OF UROLOGY (2007)
HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: Novel role of fumarate in regulation of HIF stability
JS Isaacs et al.
CANCER CELL (2005)
Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiency
NA Alam et al.
HUMAN MOLECULAR GENETICS (2003)
Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer
IPM Tomlinson et al.
NATURE GENETICS (2002)
Inherited susceptibility to uterine leiomyomas and renal cell cancer
V Launonen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
